Literature DB >> 14551742

Evaluation of serum ferritin in screening for iron deficiency in tuberculosis.

M Kotru1, U Rusia, M Sikka, S Chaturvedi, A K Jain.   

Abstract

Serum ferritin (SF) values </=10 micro g/l are diagnostic of absent Bone Marrow Iron (BMI) stores and therefore of iron deficiency (ID). However, SF, which may be elevated as a part of acute phase reaction, is an unreliable indicator of BMI stores in the setting of chronic disorders, making it difficult to diagnose ID in these patients. Thus, in chronic disorders (CD) such as tuberculosis, bone marrow examination is the only reliable way to establish ID. This study was done in order to identify levels of SF that would be indicative of absent BMI stores and also to study a combination of hematological and biochemical parameters that would be helpful in raising the predictive power of SF in patients of tuberculosis. Fifty-five tuberculosis patients were studied and classified into Iron Deplete (ID) and Iron Replete (IR) based on BMI. Raising the cut-off values of SF from </=10 micro g/l to </=30 micro g/l diagnosed 88% of ID cases correctly, as compared with 61% when cut-off levels of </=10 micro g/l were used. At cut-off values higher than 30 micro g/l, the sensitivity was markedly reduced. Therefore, raising cut-off levels of SF to </=30 micro g/l was most effective in predicting absent BMI, especially in a population where ID is highly prevalent. Combination of SF </=30 micro g/l with mean corpuscular volume (MCV), erythrocyte sedimentation rate (ESR) and total iron binding capacity (TIBC) did not improve the predictive power of SF further. Also, 89.5% cases could be correctly classified by logistic regression equations using SF with ESR and C- reactive protein (CRP).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14551742     DOI: 10.1007/s00277-003-0788-9

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  6 in total

1.  Changes of Serum Trace Elements, AFP, CEA, SF, T3, T4 and IGF-II in Different Periods of Rat Liver Cancer.

Authors:  Hong-Xu Zhang; Dan-Dan Liu; Bai-Jie Jin; Ya-Wei Wang; Qi Liu; Ru-Bing Duan; Peng Zhao; Ming-Xia Ma
Journal:  Chin J Cancer Res       Date:  2011-12       Impact factor: 5.087

2.  Iron status predicts treatment failure and mortality in tuberculosis patients: a prospective cohort study from Dar es Salaam, Tanzania.

Authors:  Sheila Isanaka; Said Aboud; Ferdinand Mugusi; Ronald J Bosch; Walter C Willett; Donna Spiegelman; Christopher Duggan; Wafaie W Fawzi
Journal:  PLoS One       Date:  2012-05-11       Impact factor: 3.240

3.  Serum or plasma ferritin concentration as an index of iron deficiency and overload.

Authors:  Maria Nieves Garcia-Casal; Sant-Rayn Pasricha; Ricardo X Martinez; Lucero Lopez-Perez; Juan Pablo Peña-Rosas
Journal:  Cochrane Database Syst Rev       Date:  2021-05-24

4.  Identification of novel host biomarkers in plasma as candidates for the immunodiagnosis of tuberculosis disease and monitoring of tuberculosis treatment response.

Authors:  Ruschca Jacobs; Stephanus Malherbe; Andre G Loxton; Kim Stanley; Gian van der Spuy; Gerhard Walzl; Novel N Chegou
Journal:  Oncotarget       Date:  2016-09-06

5.  Evaluation of a competitive hepcidin ELISA assay in the differential diagnosis of iron deficiency anaemia with concurrent inflammation and anaemia of inflammation in elderly patients.

Authors:  Torbjörn Karlsson
Journal:  J Inflamm (Lond)       Date:  2017-09-18       Impact factor: 4.981

6.  Biomarkers of iron metabolism facilitate clinical diagnosis in M ycobacterium tuberculosis infection.

Authors:  Youchao Dai; Wanshui Shan; Qianting Yang; Jiubiao Guo; Rihong Zhai; Xiaoping Tang; Lu Tang; Yaoju Tan; Yi Cai; Xinchun Chen
Journal:  Thorax       Date:  2019-10-14       Impact factor: 9.139

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.